Literature DB >> 19237429

Muscle-specific VEGF deficiency greatly reduces exercise endurance in mice.

I Mark Olfert1, Richard A Howlett, Kechun Tang, Nancy D Dalton, Yusu Gu, Kirk L Peterson, Peter D Wagner, Ellen C Breen.   

Abstract

Vascular endothelial growth factor (VEGF) is required for vasculogenesis and angiogenesis during embryonic and early postnatal life. However the organ-specific functional role of VEGF in adult life, particularly in skeletal muscle, is less clear. To explore this issue, we engineered skeletal muscle-targeted VEGF deficient mice (mVEGF-/-) by crossbreeding mice that selectively express Cre recombinase in skeletal muscle under the control of the muscle creatine kinase promoter (MCKcre mice) with mice having a floxed VEGF gene (VEGFLoxP mice). We hypothesized that VEGF is necessary for regulating both cardiac and skeletal muscle capillarity, and that a reduced number of VEGF-dependent muscle capillaries would limit aerobic exercise capacity. In adult mVEGF-/- mice, VEGF protein levels were reduced by 90 and 80% in skeletal muscle (gastrocnemius) and cardiac muscle, respectively, compared to control mice (P < 0.01). This was accompanied by a 48% (P < 0.05) and 39% (P < 0.05) decreases in the capillary-to-fibre ratio and capillary density, respectively, in the gastrocnemius and a 61% decrease in cardiac muscle capillary density (P < 0.05). Hindlimb muscle oxidative (citrate synthase, 21%; beta-HAD, 32%) and glycolytic (PFK, 18%) regulatory enzymes were also increased in mVEGF-/- mice. However, this limited adaptation to reduced muscle VEGF was insufficient to maintain aerobic exercise capacity, and maximal running speed and endurance running capacity were reduced by 34% and 81%, respectively, in mVEGF-/- mice compared to control mice (P < 0.05). Moreover, basal and dobutamine-stimulated cardiac function, measured by transthoracic echocardiography and left ventricular micromanomtery, showed only a minimal reduction of contractility (peak +dP/dt) and relaxation (peak -dP/dt, tau(E)). Collectively these data suggests adequate locomotor muscle capillary number is important for achieving full exercise capacity. Furthermore, VEGF is essential in regulating postnatal muscle capillarity, and that adult mice, deficient in cardiac and skeletal muscle VEGF, exhibit a major intolerance to aerobic exercise.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19237429      PMCID: PMC2683962          DOI: 10.1113/jphysiol.2008.164384

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  44 in total

1.  A barometric method for measuring ventilation in newborn infants.

Authors:  J E DRORBAUGH; W O FENN
Journal:  Pediatrics       Date:  1955-07       Impact factor: 7.124

2.  VEGF-dependent plasticity of fenestrated capillaries in the normal adult microvasculature.

Authors:  Tomomi Kamba; Betty Y Y Tam; Hiroya Hashizume; Amy Haskell; Barbara Sennino; Michael R Mancuso; Scott M Norberg; Shaun M O'Brien; Rachel B Davis; Lori C Gowen; Keith D Anderson; Gavin Thurston; Shuji Joho; Matthew L Springer; Calvin J Kuo; Donald M McDonald
Journal:  Am J Physiol Heart Circ Physiol       Date:  2005-09-19       Impact factor: 4.733

Review 3.  Role of vascular endothelial growth factor in the regulation of angiogenesis.

Authors:  N Ferrara
Journal:  Kidney Int       Date:  1999-09       Impact factor: 10.612

4.  Disruption of myoglobin in mice induces multiple compensatory mechanisms.

Authors:  A Gödecke; U Flögel; K Zanger; Z Ding; J Hirchenhain; U K Decking; J Schrader
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-31       Impact factor: 11.205

5.  Angiogenic growth factor mRNA responses in muscle to a single bout of exercise.

Authors:  E C Breen; E C Johnson; H Wagner; H M Tseng; L A Sung; P D Wagner
Journal:  J Appl Physiol (1985)       Date:  1996-07

6.  A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance.

Authors:  J C Brüning; M D Michael; J N Winnay; T Hayashi; D Hörsch; D Accili; L J Goodyear; C R Kahn
Journal:  Mol Cell       Date:  1998-11       Impact factor: 17.970

7.  Exercise-induced expression of angiogenesis-related transcription and growth factors in human skeletal muscle.

Authors:  T Gustafsson; A Puntschart; L Kaijser; E Jansson; C J Sundberg
Journal:  Am J Physiol       Date:  1999-02

8.  Metabolic enzymatic activities in the intercostal and serratus muscles and in the latissimus dorsi of middle-aged normal men and patients with moderate obstructive pulmonary disease.

Authors:  J Sanchez; A Brunet; G Medrano; B Debesse; J P Derenne
Journal:  Eur Respir J       Date:  1988-04       Impact factor: 16.671

9.  Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal.

Authors:  L E Benjamin; D Golijanin; A Itin; D Pode; E Keshet
Journal:  J Clin Invest       Date:  1999-01       Impact factor: 14.808

10.  VEGF is required for growth and survival in neonatal mice.

Authors:  H P Gerber; K J Hillan; A M Ryan; J Kowalski; G A Keller; L Rangell; B D Wright; F Radtke; M Aguet; N Ferrara
Journal:  Development       Date:  1999-03       Impact factor: 6.868

View more
  55 in total

1.  Evolution of the VEGF-regulated vascular network from a neural guidance system.

Authors:  Sreenivasan Ponnambalam; Mario Alberghina
Journal:  Mol Neurobiol       Date:  2011-01-28       Impact factor: 5.590

2.  Muscle intracellular oxygenation during exercise: optimization for oxygen transport, metabolism, and adaptive change.

Authors:  Peter D Wagner
Journal:  Eur J Appl Physiol       Date:  2011-04-22       Impact factor: 3.078

Review 3.  Regulation of exercise-induced fiber type transformation, mitochondrial biogenesis, and angiogenesis in skeletal muscle.

Authors:  Zhen Yan; Mitsuharu Okutsu; Yasir N Akhtar; Vitor A Lira
Journal:  J Appl Physiol (1985)       Date:  2010-10-28

4.  Angio-adaptation in unloaded skeletal muscle: new insights into an early and muscle type-specific dynamic process.

Authors:  Emilie Roudier; Charlotte Gineste; Alexandra Wazna; Kooroush Dehghan; Dominique Desplanches; Olivier Birot
Journal:  J Physiol       Date:  2010-09-27       Impact factor: 5.182

Review 5.  Genomics and genetics in the biology of adaptation to exercise.

Authors:  Claude Bouchard; Tuomo Rankinen; James A Timmons
Journal:  Compr Physiol       Date:  2011-07       Impact factor: 9.090

6.  Heat therapy promotes the expression of angiogenic regulators in human skeletal muscle.

Authors:  Alisha M Kuhlenhoelter; Kyoungrae Kim; Dustin Neff; Yaohui Nie; A Nicole Blaize; Brett J Wong; Shihuan Kuang; Julianne Stout; Qifan Song; Timothy P Gavin; Bruno T Roseguini
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2016-06-29       Impact factor: 3.619

7.  Hyperhomocysteinemia attenuates angiogenesis through reduction of HIF-1α and PGC-1α levels in muscle fibers during hindlimb ischemia.

Authors:  Sudhakar Veeranki; Srikanth Givvimani; Sathnur Pushpakumar; Suresh C Tyagi
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-02-28       Impact factor: 4.733

8.  Skeletal myofiber VEGF is essential for the exercise training response in adult mice.

Authors:  Hamid Delavar; Leonardo Nogueira; Peter D Wagner; Michael C Hogan; Daniel Metzger; Ellen C Breen
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2014-02-12       Impact factor: 3.619

9.  (-)-Epicatechin is associated with increased angiogenic and mitochondrial signalling in the hindlimb of rats selectively bred for innate low running capacity.

Authors:  Maik Hüttemann; Icksoo Lee; Guy A Perkins; Steven L Britton; Lauren G Koch; Moh H Malek
Journal:  Clin Sci (Lond)       Date:  2013-06       Impact factor: 6.124

10.  Exposure to cigarette smoke induces overexpression of von Hippel-Lindau tumor suppressor in mouse skeletal muscle.

Authors:  Vladimir T Basic; Elsa Tadele; Ali Ateia Elmabsout; Hongwei Yao; Irfan Rahman; Allan Sirsjö; Samy M Abdel-Halim
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-07-27       Impact factor: 5.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.